title: Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients.
authors.affiliation: Institut Pasteur de Lyon, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Bordet
authors.forename: M
authors.initials: M
authors.lastname: de Lorgeril
authors.forename: S
authors.initials: S
authors.lastname: Durbin
authors.forename: P
authors.initials: P
authors.lastname: Boissonnat
authors.forename: S
authors.initials: S
authors.lastname: Renaud
authors.forename: G
authors.initials: G
authors.lastname: Dureau
authors.forename: M
authors.initials: M
authors.lastname: Dechavanne
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives / Q000652:urine; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000652:urine; D016572:Cyclosporine / Q000494:pharmacology*; D011464:Epoprostenol / Q000096:biosynthesis*; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D008875:Middle Aged; D013931:Thromboxanes / Q000652:urine
chemical_list: D013931:Thromboxanes; D015121:6-Ketoprostaglandin F1 alpha; C028290:2,3-dinor-6-ketoprostaglandin F1alpha; D016572:Cyclosporine; D003404:Creatinine; D011464:Epoprostenol